DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Technologies that can change the way we measure and perceive vaccination-induced immune protection will eliminate the uncertainty and retrospective evaluation ...
Technologies that can change the way we measure and perceive vaccination-induced immune protection will eliminate the uncertainty and retrospective evaluation ...
DARPA’s Foundational Security for Food Systems (FS2) program will explore a pathway-based approach to provide advanced threat detection and warning ...
Scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) working with industry partners are among the first ...
Researchers at the School of Science at IUPUI have found that blow flies can be used as chemical sensors, with ...
Agile biomanufacturing technology incubated by DARPA reaches commercial facility milestone On Demand Pharmaceuticals, Inc. (ODP) announced on Feb. 15 the ...
The B-SURE (Biomanufacturing: Survival, Utility, and Reliability beyond Earth) program will leverage biological processes in resource limited environments. Imagine you ...
Parasites could become part of the armour of military personnel and first responders to help them counter chemical and biological ...
Personalized Protective Biosystem (PPB) program aims to develop technology that reduces the need for burdensome protective equipment while increasing individual ...
DARPA’s new project will develop “probiotics for materials” to build protective and beneficial coatings Bacteria are the most abundant and ...
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory ...
Carbon monoxide is a colorless, odorless gas that can cause headaches, dizziness and even death in certain circumstances. Since this ...
The Defense Advanced Research Projects Agency (DARPA) has awarded project funding worth up to $41 million to GE Research and a ...
A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment ...
DARPA is interested in understanding the feasibility of rapid, flexible manufacturing of DNA molecules for synthetic biology and therapeutic applications. ...
AbCellera Biologics Inc. and Eli Lilly today announced they would co-develop antibody products for the treatment of COVID-19, the disease ...
Profusa, a digital health company that is pioneering the next generation of personalized medicine, today announced the initiation of a ...
Researchers working under DARPA's Pandemic Preparedness Platform (P3) are racing to apply their experimental techniques to a true pandemic playing out ...
A new University of California, Berkeley, study finds that bats' fierce immune response to viruses could drive viruses to replicate ...
A research team led by scientists at Vanderbilt University Medical Center has developed an antibody mixture that in animals is ...
AbCellera confirms that it is mobilizing its pandemic response platform against the ongoing outbreak of a novel coronavirus (2019-nCoV) originating ...